000 01118 a2200301 4500
005 20250517162525.0
264 0 _c20180502
008 201805s 0 0 eng d
022 _a1347-5215
024 7 _a10.1248/bpb.b17-00243
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNakagawa, Takayuki
245 0 0 _aRoles of Transient Receptor Potential Ankyrin 1 in Oxaliplatin-Induced Peripheral Neuropathy.
_h[electronic resource]
260 _bBiological & pharmaceutical bulletin
_c2017
300 _a947-953 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aOrganoplatinum Compounds
_xadverse effects
650 0 4 _aOxaliplatin
650 0 4 _aPeripheral Nervous System Diseases
_xchemically induced
650 0 4 _aTRPA1 Cation Channel
_xphysiology
700 1 _aKaneko, Shuji
773 0 _tBiological & pharmaceutical bulletin
_gvol. 40
_gno. 7
_gp. 947-953
856 4 0 _uhttps://doi.org/10.1248/bpb.b17-00243
_zAvailable from publisher's website
999 _c27335200
_d27335200